We initiate coverage on the stock with a BUY rating and value the company by assigning a 1-year forward EV/EBITDA multiple of 4.0x on FY24 EBITDA. We arrive at our Mar'23 target price of Rs 225/share, implying an upside of 21% from the CMP.